We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Global Breast Cancer Diagnostics Market to Surpass USD 2 Billion by 2022

By HospiMedica International staff writers
Posted on 16 Apr 2019
Print article
The global breast cancer diagnostics market is anticipated to register a modest CAGR of 4.7% between 2017 and 2022 to surpass USD 2 billion in revenues by the end of the forecast period.

The market growth is expected to be driven by a surge in the number of breast cancer cases, thereby increasing the need for efficient and initial detection, as well as by the introduction of high-end technological assistance to provide conclusive test results. These are the latest findings of Fact.MR, (Dublin, Ireland), a market research firm.

Based on test type, BRCA is expected to dominate the global breast cancer diagnostics market with the highest revenue share and achieve sales of USD 500 million by 2022-end. However, the CA test type segment is projected to register the highest CAGR in the breast cancer diagnostics market through 2022, followed by the ER and PR test type segments. HER 2 test is expected to be the second-largest test type segment in the global breast cancer diagnostics market, whereas revenues of the EGFR mutation test type segment are likely to remain low. Hospital-associated laboratories are expected to remain the largest end-user of breast cancer diagnostics globally and record the highest revenues by 2022-end, followed by independent diagnostic laboratories.

Geographically, North America has the highest revenue share in the global breast cancer diagnostics market and will retain its leading position with projected revenues of more than USD 800 million by 2022-end. On the other hand, Europe will have the second-largest share in revenues of the global breast cancer diagnostics market, while the regional markets in Japan and the Middle East & Africa (MEA) are projected to witness a slow growth during the forecast period.

Related Links:
Fact.MR

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Forceps
BiClamp LAP

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.